Did you know every three minutes someone in the United States is diagnosed with blood cancer? Blood cancers affect the production and function of blood cells, and about half of blood cancers that occur each year are lymphoma.

Lymphoma starts in cells called lymphocytes, which are part of the body's immune system. There are more than 60 forms of lymphoma and each subtype behaves, spreads and responds to treatment differently. Lymphomas are divided into two categories: Hodgkin lymphoma and non-Hodgkin's lymphoma.

One subtype of non-Hodgkin's lymphoma is called marginal zone lymphoma (MZL), a slow-growing, rare disease. Discover more about MZL with these key facts on symptoms, diagnosis and prevalence.

.

Media inquiries: Ilke Limoncu

Email:ilimoncu@pcyc.com
Call: + 1-669-224-1836

AbbVie Inc. published this content on 19 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 19 January 2017 22:57:10 UTC.

Original documenthttps://news.abbvie.com/news/abbvie-news-briefs/shining-light-on-rare-blood-cancer.htm

Public permalinkhttp://www.publicnow.com/view/D42E7F5E85158F87C7AD4E88709F28F89342EDDB